How Food Processing Impacts Hyperkalemia and Hyperphosphatemia Management in Chronic Kidney Disease

被引:6
|
作者
Picard, Kelly [1 ,2 ]
Mager, Diana [1 ]
Richard, Caroline [1 ]
机构
[1] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada
[2] Alberta Hlth Serv, Nutr Serv, Edmonton, AB, Canada
关键词
CONSUMPTION; PHOSPHORUS; ADDITIVES; DIET; PREVALENCE; POTASSIUM; PRODUCTS; POULTRY; CANADA; SODIUM;
D O I
10.3148/cjdpr-2020-003
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Food processing has a unique impact on patients living with chronic kidney disease who may need to restrict dietary sodium, potassium, and phosphorus intake. Canada is the second largest consumer of processed food in the world. Highly processed foods tend to be more nutrient dense, contain less fibre, and are higher in sodium than unprocessed foods. To reduce the amount of sodium in processed food, Health Canada has encouraged food producers to reduce the sodium in their food. Potassium additives have been identified as an attractive alternative to sodium and their use in food processing is expected to increase. Phosphorus additives have been reported to be present in about 44% of processed foods. Given the changes in the nutrient profiles of processed foods, dietary advice on ways to reduce sodium, potassium, and phosphorus intake may be best achieved by recommending minimally processed food and encouraging unprocessed foods more often.
引用
收藏
页码:132 / 136
页数:5
相关论文
共 50 条
  • [31] The Mediterranean diet, even in hyperkalemia and chronic kidney disease
    Tablado, M. A. Maria
    HIPERTENSION Y RIESGO VASCULAR, 2024, 41 (01): : 66 - 67
  • [32] HYPERKALEMIA IN ACUTE AND CHRONIC KIDNEY DISEASE, A COMPARATIVE STUDY
    Sellami, Nada
    Jebali, Hela
    Mami, Ikram
    Beji, Soumaya
    Ben Fatma, Lilia
    Smaoui, Wided
    Krid, Madiha
    Ben Hamida, Fathi
    Rais, Lamia
    Zouaghi, Mohamed Karim
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33
  • [33] Colestilan for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis
    Locatelli, Francesco
    Dimkovic, Nada
    Spasovski, Goce
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2015, 10 (02) : 131 - 142
  • [34] Hyperphosphatemia Contributes to Skeletal Muscle Atrophy in Chronic Kidney Disease
    Heitman, Kylie
    Czaya, Brian
    Richter, Beatrice
    Campos, Isaac
    Yanucil, Christopher
    Kentrup, Dominik
    Westbrook, David
    Faul, Christian
    FASEB JOURNAL, 2021, 35
  • [35] ECONOMIC BURDEN OF HYPERPHOSPHATEMIA IN CHRONIC KIDNEY DISEASE IN CHINA: A REVIEW
    Li, X.
    Yang, L.
    VALUE IN HEALTH, 2015, 18 (03) : A187 - A187
  • [36] Optimising the treatment of hyperphosphatemia and vascular calcification in chronic kidney disease
    Cozzolino, Mario
    Brancaccio, Diego
    EXPERT OPINION ON EMERGING DRUGS, 2007, 12 (03) : 341 - 343
  • [37] Hyperkalemia in Chronic Kidney Disease in the New Era of Kidney Protection Therapies
    Valdivielso, Jose M.
    Balafa, Olga
    Ekart, Robert
    Ferro, Charles J.
    Mallamaci, Francesca
    Mark, Patrick B.
    Rossignol, Patrick
    Sarafidis, Pantelis
    del Vecchio, Lucia
    Ortiz, Alberto
    DRUGS, 2021, 81 (13) : 1467 - 1489
  • [38] Hyperkalemia in Chronic Kidney Disease in the New Era of Kidney Protection Therapies
    José M. Valdivielso
    Olga Balafa
    Robert Ekart
    Charles J. Ferro
    Francesca Mallamaci
    Patrick B. Mark
    Patrick Rossignol
    Pantelis Sarafidis
    Lucia Del Vecchio
    Alberto Ortiz
    Drugs, 2021, 81 : 1467 - 1489
  • [39] Management of Hyperkalemia in Patients with Chronic Kidney Disease Using Renin Angiotensin Aldosterone System Inhibitors
    Michelle A. Fravel
    Calvin J. Meaney
    Lama Noureddine
    Current Hypertension Reports, 2023, 25 : 395 - 404
  • [40] Utilization of Potassium Binders for the Management of Hyperkalemia in Chronic Kidney Disease: A Position Statement by US Nephrologists
    Rastogi, Anjay
    Chertow, Glenn M.
    Collins, Ashte
    Kelepouris, Ellie
    Kotzker, Wayne
    Middleton, John P.
    Rajpal, Minesh
    Roy-Chaudhury, Prabir
    ADVANCES IN KIDNEY DISEASE AND HEALTH, 2024, 31 (06): : 514 - 522